These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32692894)

  • 21. Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States.
    Patell R; Midha S; Kimani S; Martin R; Neparidze N; Jaglal M; Freed J; Key NS
    Thromb Haemost; 2020 Dec; 120(12):1725-1732. PubMed ID: 32828072
    [No Abstract]   [Full Text] [Related]  

  • 22. Alteraciones de la coagulación en la COVID-19.
    Carrillo-Esper R; Melgar-Bieberach RE; Jacinto-Flores SA; Tapia-Salazar M; Campa-Mendoza ÁN
    Cir Cir; 2020; 88(6):787-793. PubMed ID: 33254192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulopathy in COVID-19.
    Iba T; Levy JH; Levi M; Thachil J
    J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defibrotide in the COVID-19 coagulopathy: What is the timing?
    Macciò A; Madeddu C; Caocci G; Oppi S; La Nasa G
    J Thromb Haemost; 2020 Nov; 18(11):3113-3115. PubMed ID: 32945111
    [No Abstract]   [Full Text] [Related]  

  • 25. Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.
    Richardson E; García-Bernal D; Calabretta E; Jara R; Palomo M; Baron RM; Yanik G; Fareed J; Vlodavsky I; Iacobelli M; Díaz-Ricart M; Richardson PG; Carlo-Stella C; Moraleda JM
    Expert Opin Ther Targets; 2021 Jun; 25(6):423-433. PubMed ID: 34167431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy.
    Wiedermann CJ
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Title: Covid-19-associated coagulopathy].
    Nopp S; Ay C
    Dtsch Med Wochenschr; 2021 Aug; 146(15):944-949. PubMed ID: 34344026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AGA Technical Review on Coagulation in Cirrhosis.
    Intagliata NM; Davitkov P; Allen AM; Falck-Ytter YT; Stine JG
    Gastroenterology; 2021 Nov; 161(5):1630-1656. PubMed ID: 34579937
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular Disease Patient Information Page: COVID-19-related thrombosis.
    Schmaier AA; Schmaier AH
    Vasc Med; 2020 Dec; 25(6):604-607. PubMed ID: 33044129
    [No Abstract]   [Full Text] [Related]  

  • 30. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    O'Shea RS; Davitkov P; Ko CW; Rajasekhar A; Su GL; Sultan S; Allen AM; Falck-Ytter Y
    Gastroenterology; 2021 Nov; 161(5):1615-1627.e1. PubMed ID: 34579936
    [No Abstract]   [Full Text] [Related]  

  • 31. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.
    Ebrahimi R; Nasri F; Kalantari T
    Ann Hematol; 2024 Jun; 103(6):1819-1831. PubMed ID: 38349409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation of coagulation test results under direct oral anticoagulants.
    Mani H
    Int J Lab Hematol; 2014 Jun; 36(3):261-8. PubMed ID: 24750672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
    Yamada S; Asakura H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
    An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
    Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2020 - Year of COVID-19.
    Lillicrap D; Morrissey JH
    J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
    [No Abstract]   [Full Text] [Related]  

  • 36. Major coagulation disorders and parameters in COVID-19 patients.
    Teimury A; Khameneh MT; Khaledi EM
    Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered platelet and coagulation function in moderate-to-severe COVID-19.
    Litvinov RI; Evtugina NG; Peshkova AD; Safiullina SI; Andrianova IA; Khabirova AI; Nagaswami C; Khismatullin RR; Sannikova SS; Weisel JW
    Sci Rep; 2021 Aug; 11(1):16290. PubMed ID: 34381066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multisystem Assessment of the Imaging Manifestations of Coagulopathy in Hospitalized Patients With Coronavirus Disease (COVID-19).
    O'Shea A; Parakh A; Hedgire S; Lee SI
    AJR Am J Roentgenol; 2021 Apr; 216(4):1088-1098. PubMed ID: 32755217
    [No Abstract]   [Full Text] [Related]  

  • 39. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
    Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
    Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing and Reversing the Effect of Direct Oral Anticoagulants on Coagulation.
    Langer A; Connors JM
    Anesthesiology; 2020 Jul; 133(1):223-232. PubMed ID: 32217870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.